This Healthcare Stock Defied Gravity in its Heyday: Today, it Is Undervalued

Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) remains undervalued as results are bottoming and the stock rallies on recovering revenue and a slowly improving balance sheet.

| More on:

If Bausch Health Companies (TSX:BHC)(NYSE:BHC) was a buy back in 2015 (as per many analysts back then) at over $200 and even $300 a share, when debt levels were spiraling out of control, P/E multiples were in the mid-30s, and the company had a debt-to-EBITDA ratio that was untenable, what is it today after it has taken steps to address these issues and more?

Let’s take a look at what’s changed with this healthcare stock.

Although debt levels are still untenable, they have at least been managed better by instituting a company-wide goal of reducing debt and managing maturities and interest expenses — something the company’s new CEO Joseph Papa has been adamant about.

Re-financing at lower interest rates, slowly paying down debt with excess cash flow, and limiting new debt issuances have been key moves to get the debt situation under control.

Net debt was reduced by over $100 million in the most recent quarter, and although this is pretty insignificant relative to total debt on the books of over $23 billion, it is at least progress in the right direction. Three years ago, the company’s debt levels were north of $30 billion.

Furthermore, the practice of instituting sharp and egregious price increases has been scaled back with the help of regulatory pressure, and after the SEC got after the company about its accounting practices, the company’s books are being put in order.

So, with this, the company can start to get back to the business of running a profitable healthcare company that has its stakeholders’ best interests at heart, including patients in need of medical care and the company’s shareholders.

Revenue turning the corner

First-quarter total revenue came in at just over $2 billion, which represents a 4% constant-currency increase, as revenue inches its way back up after falling off a cliff in the years leading up to 2018.

Valuation still attractive

After trading at multiples as highs as over 30 times back in its heyday, Bausch stock is now trading at P/E multiples of below 10 times.

And although the company is a fraction of what it was, with revenue roughly 20% lower today compared to 2015, and EPS roughly 59% lower these days compared to 2015, we can see a bottoming of these numbers and the light at the end of the tunnel.

Final thoughts

While Bausch’s recovery remains in early stages, the healthcare sector is booming, as the population is aging rapidly, and so healthcare needs and spending will see a sustained upward trend.

The company is resolving litigation, which is removing some clouds over its stock. It is slowly reducing debt, removing another cloud. And its valuation still does not reflect much good news and actually appears undervalued for this powerhouse.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Investing

open vault at bank
Dividend Stocks

Don’t Get Cute; Just Buy Stability: Top Defensive TSX Stocks to Buy Now

A healthy risk tolerance is essential for most investors, but many stray from the tried and tested, hoping to find…

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Dividend Stocks

TFSA Investors: Buy These 3 Stocks for $3,480 Yearly Tax-Free Income

One significant benefit of a TFSA-based dividend income is that it doesn’t weigh down your tax bill.

Read more »

a-developer-typing-lines-of-ai-code-while-viewing-multiple-computer-monitors
Tech Stocks

Could Constellation Software Become the Next Berkshire Hathaway?

Constellation Software's (TSX:CSU) capital-allocation strategy is similar to that of Berkshire Hathaway (NYSE:BRK.B).

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, November 8

The TSX Composite benchmark remains on track to end the week with strong optimism as it currently trades with 2.4%…

Read more »

Canadian dollars in a magnifying glass
Dividend Stocks

3 High-Yield Dividend Stocks That Are Screaming Buys Right Now

Are you looking for great income stocks? Here's a trio of high-yield dividend stocks that pay insane yields right now.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Bank Stocks

Best Stock to Buy Right Now: TD Bank or Manulife Financial?

Manulife continues to see momentum in its business and stock price, while TD Bank stock remains down and out.

Read more »

cloud computing
Tech Stocks

3 No-Brainer Tech Stocks to Buy With $1,000 Right Now

These three Canadian tech stocks could be among the best growth opportunities in the market right now.

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Dividend Stocks

Transform a $5,000 TFSA Into a $50,000 Retirement Nest Egg

The TFSA is a powerful tool that can grow a small investment into a substantial retirement nest egg over time.

Read more »